4-Acetylbenzoic acid | CAS:586-89-0

We serve 4-Acetylbenzoic acid CAS:586-89-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Acetylbenzoic acid

Chemical Name:4-Acetylbenzoic acid
CAS.NO:586-89-0
Synonyms:4-Acetylbenzoic acid
4-acetyl benzoic acid
4-acetyl-phenylacetic acid
4'-Acetophenonecarboxylic Acid
p-acetylbenzoic acid
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 339.9±25.0 °C at 760 mmHg
Melting Point 208-210 °C(lit.)
Molecular Formula C9H8O3
Molecular Weight 164.158
Flash Point 173.6±19.7 °C
 
Specification:
Appearance:White to Off-white crystalline powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediates of Micafungin



Contact us for information like 4-Acetylbenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-acetylbenzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4′-Acetophenonecarboxylic Acid Use and application,4′-Acetophenonecarboxylic Acid technical grade,usp/ep/jp grade.


Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile manufacturer Also that day the CDC reported the first case of person-to-person transmission in Illinois between household members.1-(trichloromethyl)-3-(trifluoromethyl)benzene supplier The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.6-chloropyridine-3-carbonitrile vendor The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.